Literature DB >> 4833912

Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide.

T X O'Connell, M C Berenbaum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4833912

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  19 in total

1.  Myocardial toxicity of high-dose cyclophosphamide in rabbits treated with daunorubicin.

Authors:  B Isberg; C Paul; L Jönsson; U Svahn
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-26

Review 3.  Cyclophosphamide toxicity. Characterising and avoiding the problem.

Authors:  L H Fraiser; S Kanekal; J P Kehrer
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

4.  Prospective evaluation of chronic cardiotoxicity due to high-dose epirubicin or combination chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil.

Authors:  H Havsteen; I Brynjolf; T Svahn; P Dombernowsky; J Godtfredsen; O Munck
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C.

Authors:  F Villani; R Comazzi; G Lacaita; A Guindani; V Genitoni; A Volonterio; M C Brambilla
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

Review 6.  Lung damage from cytotoxic drugs.

Authors:  C H Collis
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 7.  Cardiotoxicity of cancer chemotherapy: implications for children.

Authors:  Valeriano C Simbre; Sarah A Duffy; Gul H Dadlani; Tracie L Miller; Steven E Lipshultz
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

8.  Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.

Authors:  B Lantz; J Adolfsson; B Lagerlöf; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 9.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

Review 10.  Adriamycin (doxorubicin) cardiotoxicity: a review.

Authors:  R T Chlebowski
Journal:  West J Med       Date:  1979-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.